AIRLINK 74.70 Increased By ▲ 0.41 (0.55%)
BOP 4.97 Increased By ▲ 0.02 (0.4%)
CNERGY 4.34 Decreased By ▼ -0.03 (-0.69%)
DFML 40.15 Increased By ▲ 1.35 (3.48%)
DGKC 85.73 Increased By ▲ 0.91 (1.07%)
FCCL 21.35 Increased By ▲ 0.14 (0.66%)
FFBL 34.15 Increased By ▲ 0.03 (0.09%)
FFL 9.67 Decreased By ▼ -0.03 (-0.31%)
GGL 10.40 Decreased By ▼ -0.02 (-0.19%)
HBL 113.60 Increased By ▲ 0.60 (0.53%)
HUBC 137.30 Increased By ▲ 1.10 (0.81%)
HUMNL 11.55 Decreased By ▼ -0.35 (-2.94%)
KEL 4.80 Increased By ▲ 0.09 (1.91%)
KOSM 4.74 Increased By ▲ 0.30 (6.76%)
MLCF 37.65 No Change ▼ 0.00 (0%)
OGDC 139.89 Increased By ▲ 3.69 (2.71%)
PAEL 25.51 Increased By ▲ 0.41 (1.63%)
PIAA 20.68 Increased By ▲ 1.44 (7.48%)
PIBTL 6.63 Decreased By ▼ -0.08 (-1.19%)
PPL 122.88 Increased By ▲ 0.78 (0.64%)
PRL 26.60 Decreased By ▼ -0.05 (-0.19%)
PTC 13.97 Increased By ▲ 0.04 (0.29%)
SEARL 58.30 Increased By ▲ 1.08 (1.89%)
SNGP 67.10 Decreased By ▼ -0.50 (-0.74%)
SSGC 10.25 No Change ▼ 0.00 (0%)
TELE 8.42 Increased By ▲ 0.02 (0.24%)
TPLP 11.12 Decreased By ▼ -0.01 (-0.09%)
TRG 64.40 Increased By ▲ 1.59 (2.53%)
UNITY 26.60 Increased By ▲ 0.10 (0.38%)
WTL 1.45 Increased By ▲ 0.10 (7.41%)
BR100 7,842 Increased By 31.5 (0.4%)
BR30 25,366 Increased By 216.4 (0.86%)
KSE100 75,138 Increased By 181.3 (0.24%)
KSE30 24,164 Increased By 80.9 (0.34%)

KARACHI: Roche Diagnostics Pakistan has introduced an innovative product CoaguChek INRange for the patients on warfarin therapy, enabling them to frequently check their International normalized ratio (INR) values conveniently and easily share the results with their consultant via their phone or any other computing device for quick and efficient therapy management.

CoaguChek INRange in partnership with Dawaai.pk will enable users to easily get their result in just one minute by a single drop of blood. This solution will save patients, especially the bed ridden and elderly ones from the hassle of going to the laboratory for testing over and over again followed by visits to their consultants.

According to research conducted by Australian Point of Care Practitioners and Integrated Cardiovascular Clinical Network, Country Health South Australia, published in US National Library of Medicine, National Institutes Health USA, regular monitoring of the anticoagulant effect is required and evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients. With this solution, patients can easily perform the test at their convenience anywhere. This solution is available nationwide at dawaai.pk where professional pharmacists and consultants are available to guide and educate the patients.

Copyright Business Recorder, 2021

Comments

Comments are closed.